US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.700
  • -0.050-6.71%
Close Jan 8 16:00 ET
  • 0.700
  • 0.0000.00%
Post 20:01 ET
63.37MMarket Cap-0.38P/E (TTM)

Verrica Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
-106.85%-38.58M
-192.83%-14.51M
-911.56%-14.81M
34.98%-4.67M
44.96%-4.59M
32.38%-18.65M
43.04%-4.95M
Net income from continuing operations
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
-173.59%-67M
-314.94%-24.61M
-29,981.93%-24.8M
-8.08%-10.99M
22.21%-6.59M
30.20%-24.49M
37.82%-5.93M
Operating gains losses
--0
----
----
76.55%2.54M
--2.48M
----
----
----
--1.44M
--0
Depreciation and amortization
62.86%342K
61.35%334K
68.32%340K
16.43%836K
7.96%217K
-34.58%210K
111.22%207K
106.12%202K
52.12%718K
-45.68%201K
Other non cash items
--572K
--516K
--483K
108.23%810K
4,190.91%472K
----
----
----
-73.02%389K
-96.95%11K
Change In working capital
4,021.71%11.02M
-152.32%-2.39M
-457.18%-2.51M
647.72%9.86M
1,269.95%4.87M
73.91%-281K
229.73%4.57M
141.52%703K
-236.45%-1.8M
61.90%-416K
-Change in receivables
363.58%10.28M
-2,135.04%-2.62M
-837.12%-3.18M
-706.78%-3.93M
-405.88%-344K
-1,839.80%-3.9M
-154.93%-117K
200.00%431K
---487K
---68K
-Change in prepaid assets
106.00%113K
-120.74%-337K
-200.71%-1.28M
228.73%587K
41.67%-420K
-140.31%-1.88M
218.00%1.63M
135.75%1.27M
16.02%-456K
-132.26%-720K
-Change in payables and accrued expense
-86.97%727K
-79.59%640K
319.57%2.02M
2,375.21%13.49M
1,189.14%5.7M
23,345.83%5.58M
330.63%3.14M
47.10%-920K
-184.11%-593K
160.97%442K
-Change in other current liabilities
-25.97%-97K
-8.22%-79K
-6.76%-79K
-10.23%-291K
4.29%-67K
-13.24%-77K
-10.61%-73K
-23.33%-74K
-34.01%-264K
-22.81%-70K
Cash from discontinued investing activities
Operating cash flow
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
-106.85%-38.58M
-192.83%-14.51M
-911.56%-14.81M
34.98%-4.67M
44.96%-4.59M
32.38%-18.65M
43.04%-4.95M
Investing cash flow
Cash flow from continuing investing activities
75.38%-16K
81.36%-11K
0
-100.67%-362K
-103.36%-227K
-103.14%-65K
-102.68%-59K
-100.03%-11K
5,514.93%54.04M
68.39%6.75M
Net PPE purchase and sale
75.38%-16K
81.36%-11K
--0
-19.87%-362K
-243.94%-227K
15.58%-65K
61.69%-59K
-120.00%-11K
65.80%-302K
72.15%-66K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
63,089.53%54.34M
55.99%6.82M
Cash from discontinued investing activities
Investing cash flow
75.38%-16K
81.36%-11K
--0
-100.67%-362K
-103.36%-227K
-103.14%-65K
-102.68%-59K
-100.03%-11K
5,514.93%54.04M
68.39%6.75M
Financing cash flow
Cash flow from continuing financing activities
-100.90%-397K
-661.90%-640K
-102.18%-661K
539.91%74.21M
-28K
361.37%44.04M
-8,300.00%-84K
168,322.22%30.28M
-150.14%-16.87M
0
Net issuance payments of debt
-100.49%-217K
--332K
---665K
200.75%44.08M
---23K
200.81%44.11M
--0
--0
-980.36%-43.75M
--0
Net common stock issuance
--0
--0
--0
12.64%30.3M
---1K
--0
--0
--30.3M
-4.33%26.9M
--0
Proceeds from stock option exercised by employees
--0
--150K
-42.86%4K
--7K
--0
--0
--0
--7K
--0
--0
Net other financing activities
-195.08%-180K
----
----
-935.29%-176K
---3K
---61K
---84K
-64.71%-28K
---17K
--0
Cash from discontinued financing activities
Financing cash flow
-100.90%-397K
-661.90%-640K
-102.18%-661K
539.91%74.21M
---27K
361.37%44.04M
-8,300.00%-84K
168,322.22%30.28M
-150.14%-16.87M
--0
Net cash flow
Beginning cash position
-42.09%31.93M
-18.37%48.94M
102.92%69.55M
117.58%34.27M
159.62%84.31M
21.37%55.14M
18.94%59.95M
117.58%34.27M
47.41%15.75M
58.85%32.47M
Current changes in cash
-130.76%-8.97M
-253.47%-17.01M
-180.25%-20.61M
90.45%35.27M
-920.06%-14.76M
325.11%29.17M
3.32%-4.81M
-25.90%25.68M
265.59%18.52M
138.38%1.8M
End cash Position
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
102.92%69.55M
102.92%69.55M
159.62%84.31M
21.37%55.14M
18.94%59.95M
117.58%34.27M
117.58%34.27M
Free cash flow
42.36%-8.57M
-246.21%-16.37M
-333.54%-19.95M
-105.46%-38.94M
-193.51%-14.73M
-951.03%-14.88M
35.54%-4.73M
44.87%-4.6M
33.42%-18.95M
43.82%-5.02M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.22%-8.56M -250.35%-16.36M -334.58%-19.95M -106.85%-38.58M -192.83%-14.51M -911.56%-14.81M 34.98%-4.67M 44.96%-4.59M 32.38%-18.65M 43.04%-4.95M
Net income from continuing operations 7.83%-22.86M -56.38%-17.19M -208.56%-20.33M -173.59%-67M -314.94%-24.61M -29,981.93%-24.8M -8.08%-10.99M 22.21%-6.59M 30.20%-24.49M 37.82%-5.93M
Operating gains losses --0 ---- ---- 76.55%2.54M --2.48M ---- ---- ---- --1.44M --0
Depreciation and amortization 62.86%342K 61.35%334K 68.32%340K 16.43%836K 7.96%217K -34.58%210K 111.22%207K 106.12%202K 52.12%718K -45.68%201K
Other non cash items --572K --516K --483K 108.23%810K 4,190.91%472K ---- ---- ---- -73.02%389K -96.95%11K
Change In working capital 4,021.71%11.02M -152.32%-2.39M -457.18%-2.51M 647.72%9.86M 1,269.95%4.87M 73.91%-281K 229.73%4.57M 141.52%703K -236.45%-1.8M 61.90%-416K
-Change in receivables 363.58%10.28M -2,135.04%-2.62M -837.12%-3.18M -706.78%-3.93M -405.88%-344K -1,839.80%-3.9M -154.93%-117K 200.00%431K ---487K ---68K
-Change in prepaid assets 106.00%113K -120.74%-337K -200.71%-1.28M 228.73%587K 41.67%-420K -140.31%-1.88M 218.00%1.63M 135.75%1.27M 16.02%-456K -132.26%-720K
-Change in payables and accrued expense -86.97%727K -79.59%640K 319.57%2.02M 2,375.21%13.49M 1,189.14%5.7M 23,345.83%5.58M 330.63%3.14M 47.10%-920K -184.11%-593K 160.97%442K
-Change in other current liabilities -25.97%-97K -8.22%-79K -6.76%-79K -10.23%-291K 4.29%-67K -13.24%-77K -10.61%-73K -23.33%-74K -34.01%-264K -22.81%-70K
Cash from discontinued investing activities
Operating cash flow 42.22%-8.56M -250.35%-16.36M -334.58%-19.95M -106.85%-38.58M -192.83%-14.51M -911.56%-14.81M 34.98%-4.67M 44.96%-4.59M 32.38%-18.65M 43.04%-4.95M
Investing cash flow
Cash flow from continuing investing activities 75.38%-16K 81.36%-11K 0 -100.67%-362K -103.36%-227K -103.14%-65K -102.68%-59K -100.03%-11K 5,514.93%54.04M 68.39%6.75M
Net PPE purchase and sale 75.38%-16K 81.36%-11K --0 -19.87%-362K -243.94%-227K 15.58%-65K 61.69%-59K -120.00%-11K 65.80%-302K 72.15%-66K
Net investment purchase and sale ---- ---- ---- --0 ---- ---- ---- ---- 63,089.53%54.34M 55.99%6.82M
Cash from discontinued investing activities
Investing cash flow 75.38%-16K 81.36%-11K --0 -100.67%-362K -103.36%-227K -103.14%-65K -102.68%-59K -100.03%-11K 5,514.93%54.04M 68.39%6.75M
Financing cash flow
Cash flow from continuing financing activities -100.90%-397K -661.90%-640K -102.18%-661K 539.91%74.21M -28K 361.37%44.04M -8,300.00%-84K 168,322.22%30.28M -150.14%-16.87M 0
Net issuance payments of debt -100.49%-217K --332K ---665K 200.75%44.08M ---23K 200.81%44.11M --0 --0 -980.36%-43.75M --0
Net common stock issuance --0 --0 --0 12.64%30.3M ---1K --0 --0 --30.3M -4.33%26.9M --0
Proceeds from stock option exercised by employees --0 --150K -42.86%4K --7K --0 --0 --0 --7K --0 --0
Net other financing activities -195.08%-180K ---- ---- -935.29%-176K ---3K ---61K ---84K -64.71%-28K ---17K --0
Cash from discontinued financing activities
Financing cash flow -100.90%-397K -661.90%-640K -102.18%-661K 539.91%74.21M ---27K 361.37%44.04M -8,300.00%-84K 168,322.22%30.28M -150.14%-16.87M --0
Net cash flow
Beginning cash position -42.09%31.93M -18.37%48.94M 102.92%69.55M 117.58%34.27M 159.62%84.31M 21.37%55.14M 18.94%59.95M 117.58%34.27M 47.41%15.75M 58.85%32.47M
Current changes in cash -130.76%-8.97M -253.47%-17.01M -180.25%-20.61M 90.45%35.27M -920.06%-14.76M 325.11%29.17M 3.32%-4.81M -25.90%25.68M 265.59%18.52M 138.38%1.8M
End cash Position -72.77%22.96M -42.09%31.93M -18.37%48.94M 102.92%69.55M 102.92%69.55M 159.62%84.31M 21.37%55.14M 18.94%59.95M 117.58%34.27M 117.58%34.27M
Free cash flow 42.36%-8.57M -246.21%-16.37M -333.54%-19.95M -105.46%-38.94M -193.51%-14.73M -951.03%-14.88M 35.54%-4.73M 44.87%-4.6M 33.42%-18.95M 43.82%-5.02M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Oracle
ORCL
+0.69%
Salesforce
CRM
+0.61%
Microsoft
MSFT
+0.52%
Cisco
CSCO
+0.46%
Broadcom
AVGO
+0.29%

Unlock the Full List